OAM
AGIO icon

Oppenheimer Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Oppenheimer Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11
Closed -$1K – 1600
2019
Q2 		$1K Hold
11
– – ﹤0.01% 1602
2019
Q1 		$1K Hold
11
– – ﹤0.01% 1576
2018
Q4 		$1K Buy
+11
New +$679 ﹤0.01% 1604
2017
Q4 		– Sell
-37
Closed -$2K – 1106
2017
Q3 		$2K Sell
37
-1,464
-98% -$87.9K ﹤0.01% 1617
2017
Q2 		$77K Sell
1,501
-78
-5% -$3.99K ﹤0.01% 1255
2017
Q1 		$92K Buy
+1,579
New +$75.7K ﹤0.01% 1205

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oppenheimer Asset Management's AGIO Position: Q3 2019 in Review

Oppenheimer Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 11 shares — an estimated $1K sold.

Oppenheimer Asset Management first reported a position in AGIO in Q1 2017 and held it in 6 quarters. The position peaked at $92K in Q1 2017. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Oppenheimer Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Oppenheimer Asset Management sold 11 Agios Pharmaceuticals shares in Q3 2019, an estimated $1K.
  • Oppenheimer Asset Management first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 6 quarters.
  • Oppenheimer Asset Management's Agios Pharmaceuticals position peaked at $92K in Q1 2017.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Oppenheimer Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.